UNSPSC 85444905: The diagnosis of antithrombotic drugs or platelet-aggregation inhibitors

In this classification, this covers the group of activities that yields a diagnosis of antithrombotic drugs [platelet-aggregation inhibitors]. Antithrombotic drugs [platelet-aggregation inhibitors] is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y44.4.

UNSPSC 85444905, the diagnosis of antithrombotic drugs or platelet-aggregation inhibitors, is a Commodity code with minimal recent state and local procurement activity directly aligned to its nominal scope. The three most recent opportunities posted under this code — a diagnostic imaging PACS system procurement from San Mateo Medical Center, a special education contracted services RFP from Birdville Independent School District in Texas, and a temporary health professional staffing qualification vehicle from Santa Clara County Health System — show no meaningful connection to antithrombotic drug diagnosis or testing. The code appears to see little relevant state and local solicitation activity at present.

The mismatch between the code's defined scope and the work actually being tagged to it signals either misclassification in the source records or substantively different procurement patterns than the UNSPSC taxonomy anticipates. State and local healthcare procurement offices, school districts, and health systems do not appear to be using this code for its intended purpose in the recent opportunity window. Firms pursuing state and local contracts in clinical laboratory diagnostics, hematology testing services, or related pharmaceutical-assessment work should monitor this code for future activity but should not rely on current posted opportunities to characterize demand or establish competitive strategy.